1. |
- Pfeffer, W. Tad, et al.
(författare)
-
The Randolph Glacier Inventory : a globally complete inventory of glaciers
- 2014
-
Ingår i: Journal of Glaciology. - 0022-1430 .- 1727-5652. ; 60:221, s. 537-552
-
Tidskriftsartikel (refereegranskat)abstract
- The Randolph Glacier Inventory (RGI) is a globally complete collection of digital outlines of glaciers, excluding the ice sheets, developed to meet the needs of the Fifth Assessment of the Intergovernmental Panel on Climate Change for estimates of past and future mass balance. The RGI was created with limited resources in a short period. Priority was given to completeness of coverage, but a limited, uniform set of attributes is attached to each of the similar to 198 000 glaciers in its latest version, 3.2. Satellite imagery from 1999-2010 provided most of the outlines. Their total extent is estimated as 726 800 +/- 34 000 km(2). The uncertainty, about +/- 5%, is derived from careful single-glacier and basin-scale uncertainty estimates and comparisons with inventories that were not sources for the RGI. The main contributors to uncertainty are probably misinterpretation of seasonal snow cover and debris cover. These errors appear not to be normally distributed, and quantifying them reliably is an unsolved problem. Combined with digital elevation models, the RGI glacier outlines yield hypsometries that can be combined with atmospheric data or model outputs for analysis of the impacts of climatic change on glaciers. The RGI has already proved its value in the generation of significantly improved aggregate estimates of glacier mass changes and total volume, and thus actual and potential contributions to sea-level rise.
|
|
2. |
- Yao, T. D., et al.
(författare)
-
The imbalance of the Asian water tower
- 2022
-
Ingår i: Nature Reviews Earth & Environment. - : Springer Science and Business Media LLC. - 2662-138X.
-
Tidskriftsartikel (refereegranskat)abstract
- The Hindu Kush-Karakoram-Himalayan system, named the Third Pole because it is the largest global store of frozen water after the polar regions, provides a reliable water supply to almost 2 billion people. Marked atmospheric warming has changed the balance of this so-called Asian water tower and altered water resources in downstream countries. In this Review, we synthesize observational evidence and model projections that describe an imbalance in the Asian water tower caused by accelerated transformation of ice and snow into liquid water. This phase change is associated with a south-north disparity due to the spatio-temporal interaction between the westerlies and the Indian monsoon. A corresponding spatial imbalance is exhibited by alterations in freshwater resources in endorheic or exorheic basins. Global warming is expected to amplify this imbalance, alleviating water scarcity in the Yellow and Yangtze River basins and increasing scarcity in the Indus and Amu Darya River basins. However, the future of the Asian water tower remains highly uncertain. Accurate predictions of future water supply require the establishment of comprehensive monitoring stations in data-scarce regions and the development of advanced coupled atmosphere-cryosphere-hydrology models. Such models are needed to inform the development of actionable policies for sustainable water resource management. Atmospheric warming has imbalanced the Hindu Kush-Karakoram-Himalayan system (the Asian water tower (AWT)). Yao et al. review observed changes in atmospheric water and freshwater AWT constituents, focusing on their future consequences for freshwater resources and vulnerable societies across downstream basins.
|
|
3. |
- Gardner, Alex S., et al.
(författare)
-
A Reconciled Estimate of Glacier Contributions to Sea Level Rise : 2003 to 2009
- 2013
-
Ingår i: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 340:6134, s. 852-857
-
Tidskriftsartikel (refereegranskat)abstract
- Glaciers distinct from the Greenland and Antarctic Ice Sheets are losing large amounts of water to the world's oceans. However, estimates of their contribution to sea level rise disagree. We provide a consensus estimate by standardizing existing, and creating new, mass-budget estimates from satellite gravimetry and altimetry and from local glaciological records. In many regions, local measurements are more negative than satellite-based estimates. All regions lost mass during 2003-2009, with the largest losses from Arctic Canada, Alaska, coastal Greenland, the southern Andes, and high-mountain Asia, but there was little loss from glaciers in Antarctica. Over this period, the global mass budget was -259 +/- 28 gigatons per year, equivalent to the combined loss from both ice sheets and accounting for 29 +/- 13% of the observed sea level rise.
|
|
4. |
- Mattsson, S., et al.
(författare)
-
Radiation Dose to Patients from from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances.
- 2015
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- This report provides a compendium of current information relating to radiation dose to patients, including biokinetic models, biokinetic data, dose coefficients for organ and tissue absorbed doses, and effective dose for major radiopharmaceuticals based on the radiation protection guidance given in Publication 60 (ICRP, 1991). These data were mainly compiled from Publications 53 , 80, and 106 (ICRP, 1987, 1998, 2008), and related amendments and corrections. This report also includes new information for 82 Rb-chloride, iodide (123 I, 124 I, 125 I, and 131 I) and 123 Ilabelled 2.-carbomethoxy 3.-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FPCIT). The coefficients tabulated in this publication will be superseded in due course by values calculated using new International Commission on Radiation Units and Measurements/International Commission on Radiological Protection adult and paediatric reference phantoms and Publication 103 methodology (ICRP, 2007). The data presented in this report are intended for diagnostic nuclear medicine and not for therapeutic applications.
|
|
5. |
- Sechopoulos, Ioannis, et al.
(författare)
-
Radiation dosimetry in digital breast tomosynthesis : report of AAPM Tomosynthesis Subcommittee Task Group 223.
- 2014
-
Ingår i: Medical physics. - : Wiley. - 2473-4209 .- 0094-2405. ; 41:9
-
Tidskriftsartikel (refereegranskat)abstract
- The radiation dose involved in any medical imaging modality that uses ionizing radiation needs to be well understood by the medical physics and clinical community. This is especially true of screening modalities. Digital breast tomosynthesis (DBT) has recently been introduced into the clinic and is being used for screening for breast cancer in the general population. Therefore, it is important that the medical physics community have the required information to be able to understand, estimate, and communicate the radiation dose levels involved in breast tomosynthesis imaging. For this purpose, the American Association of Physicists in Medicine Task Group 223 on Dosimetry in Tomosynthesis Imaging has prepared this report that discusses dosimetry in breast imaging in general, and describes a methodology and provides the data necessary to estimate mean breast glandular dose from a tomosynthesis acquisition. In an effort to maximize familiarity with the procedures and data provided in this Report, the methodology to perform the dose estimation in DBT is based as much as possible on that used in mammography dose estimation.
|
|
6. |
- Yonekura, Y, et al.
(författare)
-
ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals.
- 2019
-
Ingår i: Annals of the ICRP. - : SAGE Publications. - 1872-969X .- 0146-6453. ; 48:1, s. 5-95
-
Tidskriftsartikel (refereegranskat)abstract
- Radiopharmaceuticals are increasingly used for the treatment of various cancers with novel radionuclides, compounds, tracer molecules, and administration techniques. The goal of radiation therapy, including therapy with radiopharmaceuticals, is to optimise the relationship between tumour control probability and potential complications in normal organs and tissues. Essential to this optimisation is the ability to quantify the radiation doses delivered to both tumours and normal tissues. This publication provides an overview of therapeutic procedures and a framework for calculating radiation doses for various treatment approaches. In radiopharmaceutical therapy, the absorbed dose to an organ or tissue is governed by radiopharmaceutical uptake, retention in and clearance from the various organs and tissues of the body, together with radionuclide physical half-life. Biokinetic parameters are determined by direct measurements made using techniques that vary in complexity. For treatment planning, absorbed dose calculations are usually performed prior to therapy using a trace-labelled diagnostic administration, or retrospective dosimetry may be performed on the basis of the activity already administered following each therapeutic administration. Uncertainty analyses provide additional information about sources of bias and random variation and their magnitudes; these analyses show the reliability and quality of absorbed dose calculations. Effective dose can provide an approximate measure of lifetime risk of detriment attributable to the stochastic effects of radiation exposure, principally cancer, but effective dose does not predict future cancer incidence for an individual and does not apply to short-term deterministic effects associated with radiopharmaceutical therapy. Accident prevention in radiation therapy should be an integral part of the design of facilities, equipment, and administration procedures. Minimisation of staff exposures includes consideration of equipment design, proper shielding and handling of sources, and personal protective equipment and tools, as well as education and training to promote awareness and engagement in radiological protection. The decision to hold or release a patient after radiopharmaceutical therapy should account for potential radiation dose to members of the public and carers that may result from residual radioactivity in the patient. In these situations, specific radiological protection guidance should be provided to patients and carers.
|
|